首页> 外文期刊>Buletin Penelitian Sistem Kesehatan >Expense of INA CBGS Claim and Real Expense of Catastropic Diseases Inpatient Jamkesmas Participant at Hospital Study in 10 Ministry of Health Hospital of January to March 2012
【24h】

Expense of INA CBGS Claim and Real Expense of Catastropic Diseases Inpatient Jamkesmas Participant at Hospital Study in 10 Ministry of Health Hospital of January to March 2012

机译:2012年1月至2012年3月10日在卫生部10医院参加INA CBGS索赔费用和催化疾病住院患者Jamkesmas的实际费用

获取原文
           

摘要

Background:The implementation of INA-CBGs system on hospital financing of catastropic diseases (heart, cancer, stroke) to Jamkesmas members at inpatient hospital, giving consequences catastropic diseases represent threat to more expense of Jamkesmas financing period of coming, while other side hospital feel that INA-CBGs claim that lower of hospital tariff. The purpose of this research is to conduct expense of medication of catastropic disease anf comparison of INA CBGs claim with real expense based on hospital tariff. Methods: Research type is observational with research cross sectional layout is according to hospital perspective. Data taken by using retrospective method taken away by medical record document. The research subjects are lodging patient at 10 Ministry of Health hospital within periode January–March 2012. Data analysis conducted descriptively. Results:The result of this strudy indicate that inpatient hospital of Jamkesmas members by catastropic disease is heart disease 37.11%, cancer 23.54% and stroke 39.35%. Conclusion: The average real expense inpatient hospital in A class much more compared to class of B and special hospital. Expense of INA CBGs claim much more of A class hospital compared to B class and special hospital. Component of many expense is accomodation cost, room action, laboratory, non surgical operation for the heart, surgical operation for cancer and the medicine expense. Expense of disease catastropic pursuant to compared to bigger claim based on INA-CBGs of real expense to hospital tariff, so that for hospital catastropic disease not lose. So, the policy of ladder refferal to Jamkesmas participant have to observe tightly so that health services to poor community become more well quality guaranted, exepense and sustainability
机译:背景:INA-CBGs系统在住院医院对Jamkesmas成员实施催化性疾病(心脏病,癌症,中风)的医院筹资系统的实施,导致催化性疾病的后果威胁着即将到来的Jamkesmas筹资期的更多费用,而其他医院则感到INA-CBG声称降低医院收费。这项研究的目的是通过与INA CBG索赔与基于医院收费的实际费用进行比较来进行催化性疾病的药物费用。方法:研究类型是观察性的,研究横截面的布局要根据医院的角度。通过回顾性方法获取的数据被病历文件带走。研究对象在2012年1月至2012年3月期间在卫生部10医院住院治疗。以描述性方式进行数据分析。结果:该研究结果表明,Jamkesmas成员住院的触媒性疾病为心脏病37.11%,癌症23.54%和中风39.35%。结论:与B级和专科医院相比,A级住院病人的平均实际费用要高得多。与B级和专科医院相比,INA CBG的费用要多得多。许多费用的组成部分是住宿费用,房间行动,实验室,心脏的非外科手术,癌症的外科手术和药品费用。相对于基于INA-CBG的更大的索赔,疾病反应性费用的依据是医院费用的实际支出,因此对于医院催化性疾病不会造成损失。因此,必须严格遵守针对Jamkesmas参与者的阶梯式推广政策,以确保为贫困社区提供的医疗服务质量得到更好的保证,超支和可持续性

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号